Literature DB >> 30406992

Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.

Jessica R Murray, Clementina A Mesaros, Volker M Arlt1,2, Albrecht Seidel3, Ian A Blair, Trevor M Penning.   

Abstract

3-Nitrobenzanthrone (3-NBA) is a potent mutagen and suspected human carcinogen detected in diesel exhaust particulate and ambient air pollution. It requires metabolic activation via nitroreduction to promote DNA adduct formation and tumorigenesis. NAD(P)H:quinone oxidoreductase 1 (NQO1) has been previously implicated as the major nitroreductase responsible for 3-NBA activation, but it has recently been reported that human aldo-keto reductase 1C3 (AKR1C3) displays nitroreductase activity toward the chemotherapeutic agent PR-104A. We sought to determine whether AKR1C isoforms could display nitroreductase activity toward other nitrated compounds and bioactivate 3-NBA. Using discontinuous enzymatic assays monitored by UV-HPLC, we determined that AKR1C1-1C3 catalyze three successive two-electron nitroreductions toward 3-NBA to form the reduced product 3-aminobenzanthrone (3-ABA). Evidence of the nitroso- and hydroxylamino- intermediates were obtained by UPLC-HRMS. Km, kcat, and kcat/ Km values were determined for recombinant AKR1C and NQO1 and compared. We found that AKR1C1, AKR1C3, and NQO1 have very similar apparent catalytic efficiencies (8 vs 7 min-1 mM-1) despite the higher kcat of NQO1 (0.058 vs 0.012 min-1). AKR1C1-1C3 possess a Km much lower than that of NQO1, which suggests that they may be more important than NQO1 at the low concentrations of 3-NBA to which humans are exposed. Given that inhalation represents the primary source of 3-NBA exposure, we chose to evaluate the relative importance of AKR1C1-1C3 and NQO1 in human lung epithelial cell lines. Our data suggest that the combined activities of AKR1C1-1C3 and NQO1 contribute equally to the reduction of 3-NBA in A549 and HBEC3-KT cell lines and together represent approximately 50% of the intracellular nitroreductase activity toward 3-NBA. These findings have significant implications for the metabolism of nitrated polycyclic aromatic hydrocarbons and suggest that the hitherto unrecognized nitroreductase activity of AKR1C enzymes should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30406992      PMCID: PMC6319660          DOI: 10.1021/acs.chemrestox.8b00250

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  92 in total

1.  DNA adduct formation by the ubiquitous environmental contaminant 3-nitrobenzanthrone in rats determined by (32)P-postlabeling.

Authors:  V M Arlt; C A Bieler; W Mier; M Wiessler; H H Schmeiser
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

2.  Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase.

Authors:  Volker M Arlt; Hansruedi Glatt; Eva Muckel; Ulrike Pabel; Bernd L Sorg; Heinz H Schmeiser; David H Phillips
Journal:  Carcinogenesis       Date:  2002-11       Impact factor: 4.944

3.  DNA adduct formation by the environmental contaminant 3-nitrobenzanthrone after intratracheal instillation in rats.

Authors:  Christian A Bieler; Michael G Cornelius; Reinhold Klein; Volker M Arlt; Manfred Wiessler; David H Phillips; Heinz H Schmeiser
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

4.  The presence of mutagens/carcinogens in the excised lung and analysis of lung cancer induction.

Authors:  H Tokiwa; N Sera; K Horikawa; Y Nakanishi; N Shigematu
Journal:  Carcinogenesis       Date:  1993-09       Impact factor: 4.944

5.  Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs.

Authors:  Michael C Byrns; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2008-11-01       Impact factor: 5.192

6.  Induction of AKR1C2 by phase II inducers: identification of a distal consensus antioxidant response element regulated by NRF2.

Authors:  Huan Lou; Shouying Du; Qing Ji; Andrew Stolz
Journal:  Mol Pharmacol       Date:  2006-02-14       Impact factor: 4.436

7.  Regio- and stereospecificity of homogeneous 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons.

Authors:  T E Smithgall; R G Harvey; T M Penning
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

8.  Lung cancer in railroad workers exposed to diesel exhaust.

Authors:  Eric Garshick; Francine Laden; Jaime E Hart; Bernard Rosner; Thomas J Smith; Douglas W Dockery; Frank E Speizer
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

9.  Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.

Authors:  A Kenneth MacLeod; Lourdes Acosta-Jimenez; Philip J Coates; Michael McMahon; Frank A Carey; Tadashi Honda; Colin J Henderson; C Roland Wolf
Journal:  Br J Cancer       Date:  2016-11-08       Impact factor: 7.640

Review 10.  Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.

Authors:  Marie Stiborová; Eva Frei; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

View more
  2 in total

1.  Induction of the Antioxidant Response by the Transcription Factor NRF2 Increases Bioactivation of the Mutagenic Air Pollutant 3-Nitrobenzanthrone in Human Lung Cells.

Authors:  Jessica R Murray; Laureano de la Vega; John D Hayes; Ling Duan; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2019-11-20       Impact factor: 3.739

Review 2.  Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.

Authors:  Nuria Camiña; Trevor M Penning
Journal:  Br J Cancer       Date:  2021-11-29       Impact factor: 9.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.